THE MISBOURNE SURGERY
CHURCH LANE, CHALFONT ST. PETER, GERRARDS CROSSHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 12 | 18 | 66.7% | |
HF 4 | 2011 | 18 | 22 | 81.8% | |
HF 4 | 2012 | 23 | 25 | 92.0% | |
HF 4 | 2013 | 20 | 25 | 80.0% | |
HF004 | 2014 | 18 | 20 | 90.0% | |
HF004 | 2015 | 38 | 44 | 86.4% | |
HF004 | 2016 | 43 | 48 | 89.6% | |
HF004 | 2017 | 66 | 72 | 91.7% | |
HF004 | 2019 | 48 | 50 | 96.0% | |
HF004 | 2020 | 61 | 70 | 87.1% | |
HF006 | 2021 | 73 | 82 | 89.0% | |
HF006 | 2022 | 77 | 79 | 97.5% | |
HF006 | 2023 | 71 | 72 | 98.6% |